MEDANTA · Concall Summary
GLOBAL HEALTH LIMITED
Management reported that Global Health Limited, operating under the Medanta brand, experienced robust growth in Q1 FY27, with consolidated income reaching INR 13,262 million, a 26% year-on-year increase. EBITDA, excluding the Noida facility, grew by 24% to INR 3,201 million, with margins improving to 25.8%. The company highlighted a 28% increase in inpatient volumes and a 34% rise in outpatient volumes, reflecting strong demand across specialties. Management noted the successful onboarding of over 70 doctors, enhancing clinical capabilities. The Noida facility showed significant improvement, with a reduction in EBITDA losses and a total income of INR 855 million. The company also announced plans to expand its Guwahati hospital to a 650-bed facility. Overall, management expressed confidence in their long-term growth strategy and commitment to delivering high-quality healthcare.
Management emphasized strong growth and operational improvements during the quarter.
View source filing →Earlier concalls
- 2026-07-30 — The investor presentation for Global Health Limited (Medanta) reported a revenue growth of 26% year-on-year for Q1 FY202…
- 2026-05-20 — Management reported on the Q4 FY26 earnings conference call that Global Health Limited, also known as Medanta, achieved …
- 2026-05-14 — The investor presentation for Global Health Limited (Medanta) detailed the company's performance for the fourth quarter …
See MEDANTA's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free